The Bi-(AID-1-T) G-Quadruplex Has a Janus Effect on Primary and Recurrent Gliomas: Anti-Proliferation and...

Area of Science:

• Neuro-oncology
• Cancer Biology
• Molecular Therapy

Background:

• High-grade gliomas (HGGs) remain incurable, with low patient survival rates and frequent recurrence.
• Tumor resistance and enhanced cell migration are key factors driving HGG recurrence.
• Current therapeutic development often overlooks the impact on cell migration, focusing solely on anti-proliferative effects.

Purpose of the Study:

• To investigate the effect of the anti-proliferative aptamer bi-(AID-1-T) on glioma cell migration.
• To evaluate the impact of bi-(AID-1-T) on primary and recurrent human glioma cell cultures.
• To assess the potential of therapeutic agents to induce invasive properties in HGG cells.

Main Methods:

• Culturing eight distinct human glioma cell lines (Grades III and IV) derived from patient tumor tissue.
• Exposing glioma cells to the anti-proliferative aptamer bi-(AID-1-T).
• Analyzing changes in glioma cell migration patterns post-treatment.

Main Results:

• The aptamer bi-(AID-1-T) demonstrated significant anti-proliferative activity.
• Bi-(AID-1-T) exposure induced increased migration in recurrent glioma cells.
• Differential effects on cell migration were observed between primary and recurrent tumor cells.

Conclusions:

• Therapeutic molecules targeting gliomas must be evaluated for their impact on cell invasiveness.
• The anti-proliferative aptamer bi-(AID-1-T) may inadvertently promote HGG recurrence by stimulating cell migration.
• Considering both anti-proliferative and pro-migratory effects is crucial for developing effective HGG treatments.